UNSPSC 51182208: Carboprost

This classification denotes a prostaglandin analogue with the molecular formula C21H36O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7B5032XT6O, chemically known as 9,11,15-trihydroxy-15-methylprosta-5,13-dien-1-oic acid (5z,9alpha,11alpha,13e,15s)- but generally known as carboprost, which bears US NIH Compound Identifier 5281005. Carboprost most often comes in base, methyl, methyl ester, and tromethamine forms.

UNSPSC 51182208 Carboprost is a Commodity code capturing pharmaceutical products, specifically prostaglandin analogs used in obstetric and gynecological clinical settings. State and local governments procure carboprost and related pharmaceuticals through cooperative purchasing vehicles and multi-source generic drug programs that aggregate demand across state health departments, Medicaid agencies, hospital systems, and correctional facilities. The work involves establishing framework agreements with pharmaceutical manufacturers and distributors to supply identified products at negotiated pricing, with vendors required to meet cGMP and Drug Supply Chain Security Act compliance, maintain relationships with authorized wholesalers, and demonstrate price competitiveness across flat, net, and WAC-minus pricing structures. Issuing bodies include state purchasing offices administering multistate cooperative agreements, state Medicaid agencies, and regional health procurement consortia.

The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP in January 2026 (solicitation S1070000015802) to establish multiple contracts for generic multi-source pharmaceuticals and OTC products distributed across participating state and local government facilities including Oregon, with proposals due March 26, 2026. The procurement requires vendors to supply products through three authorized wholesalers—AmerisourceBergen Drug Corporation (Cencora), Cardinal Health 110 and 112, and Morris & Dickson Co., LLC—with awarded vendors effective July 1, 2026. Evaluation weighs price competitiveness at 75 percent, fixed pricing and compliance with administrative fee and EDI requirements at 20 percent combined, and agreement to a 3 percent administrative fee at 5 percent. Vendors must carry commercial general liability of $5,000,000 per occurrence, network security and privacy liability of $2,000,000, and professional liability of $2,000,000. The contract term runs two years for new responders with optional MMCAP extensions, or aligns with incumbent expiration dates through June 30, 2028.